Literature DB >> 16288819

Successful treatment of severe unconjugated hyperbilirubinemia via induction of UGT1A1 by rifampicin.

Ewa Ellis1, Martin Wagner, Frank Lammert, Antal Nemeth, Judith Gumhold, Christian P Strassburg, Christian Kylander, Despina Katsika, Michael Trauner, Curt Einarsson, Hanns-Ulrich Marschall.   

Abstract

We report two patients with uncommon Gilbert's syndrome with severe unconjugated hyperbilirubinemia which was reduced from 200 to 60-90 micromol/L by long-term administration of rifampicin. Hepatic induction of bilirubin-glucuronosyltransferase was suggested by increased relative amounts of conjugated serum bilirubin. This molecular mechanism was confirmed in primary cultures of human hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16288819     DOI: 10.1016/j.jhep.2005.09.011

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  6 in total

1.  Bone mineral densities in individuals with Gilbert's syndrome: a cross-sectional, case-control pilot study.

Authors:  G Y Minuk; R Greenberg; J Uhanova; K Hawkins; W D Leslie
Journal:  Can J Gastroenterol       Date:  2009-06       Impact factor: 3.522

2.  CYP3A4-mediated effects of rifampicin on the pharmacokinetics of vilaprisan and its UGT1A1-mediated effects on bilirubin glucuronidation in humans.

Authors:  Niladri Chattopadhyay; Tobias Kanacher; Manuela Casjens; Sebastian Frechen; Sandra Ligges; Torsten Zimmermann; Antje Rottmann; Bart Ploeger; Joachim Höchel; Marcus-Hillert Schultze-Mosgau
Journal:  Br J Clin Pharmacol       Date:  2018-10-11       Impact factor: 4.335

3.  Primary myelofibrosis with thrombophilia as first symptom combined with thalassemia and Gilbert syndrome: A case report.

Authors:  Guzailinuer Wufuer; Kaisaer Wufuer; Tu Ba; Tao Cui; Ling Tao; Ling Fu; Ming Mao; Ming-Hui Duan
Journal:  World J Clin Cases       Date:  2022-05-06       Impact factor: 1.534

Review 4.  Nuclear receptors as therapeutic targets in cholestatic liver diseases.

Authors:  Gernot Zollner; Michael Trauner
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

5.  Limited influence of UGT1A1*28 and no effect of UGT2B7*2 polymorphisms on UGT1A1 or UGT2B7 activities and protein expression in human liver microsomes.

Authors:  Vincent C Peterkin; Jonathan N Bauman; Theunis C Goosen; Lee Menning; Michael Z Man; Joseph D Paulauskis; J Andrew Williams; Scott P Myrand
Journal:  Br J Clin Pharmacol       Date:  2007-06-06       Impact factor: 4.335

6.  Substantial effect of efavirenz monotherapy on bilirubin levels in healthy volunteers.

Authors:  Ingrid F Metzger; Troy C Quigg; Noam Epstein; Abdulateef O Aregbe; Nancy Thong; John T Callaghan; David A Flockhart; Anne T Nguyen; Colleen K Stevens; Samir K Gupta; Zeruesenay Desta
Journal:  Curr Ther Res Clin Exp       Date:  2014-09-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.